EGFR-IN-38
Product Specifications
CAS Number
2711105-50-7
Target
Others, EGFR
Related Pathways
JAK/STAT signaling, Others, Tyrosine Kinase/Adaptors, Angiogenesis
Bioactivity
EGFR-IN-38 is a low-toxicity, acrylamide derivative antitumor agent that is a potent inhibitor of EGFR. Among others, overexpression and mutation of the epidermal growth factor receptor (EGFR) has been shown to lead to uncontrolled cell growth and is associated with the progression of most cancer diseases, especially NSCLC. EGFR-IN-38 exhibits potential for research in EGFR mutation-related diseases.
Smiles
NC1=C2N(N=C(C2=NC=N1)C3CN(C(C=C)=O)CCC3)C4=CC(Cl)=C(OCC5=CC=CC=N5)C=C4
Molecular Formula
C25H24ClN7O2
Molecular Weight
489.96
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNCB1994-100 1x 100 µL
MMP3 (Marker of Metastasis and Rheumatoid Arthritis) (MMP3/1994R), Biotin conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
LC422599 20 µg
Liver Carboxylesterase 1 (CES1) (NM_001025194) Human Over-expression Lysate
Sign In for Pricing
View Details 
